Physician profile
Aran Yoo
NPI 1023512217
$2,436.00
in general payments reported to CMS, 2019-2025
9 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $115 · 2023: $123 · 2024: $507 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982 · Long Term Medical Supply Or Device Loan: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.54 |
| Long Term Medical Supply Or Device Loan | $139.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $1,200.00 | 2021 | |
| Integra Lifesciences Corporation | $399.54 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baxter Healthcare | $238.99 | 2024-2025 | |
| Motiva USA, LLC | $125.00 | 2025 | |
| Abbvie INC. | $122.57 | 2023 | |
| Innovation Technologies INC | $115.02 | 2022 | |
| Organogenesis INC. | $93.76 | 2024 | Puraply Franchise |
| Stryker Corporation | $74.63 | 2025 | Na |
| Acera Surgical, INC. | $66.49 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aran Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.